Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • Cy3 NHS Ester: Precision Fluorescent Dye for Protein & Or...

    2025-10-24

    Cy3 NHS Ester (Non-Sulfonated): Advanced Fluorescent Dye for Protein and Organelle Labeling

    Principle and Setup: The Science Behind Cy3 NHS Ester (Non-Sulfonated)

    Cy3 NHS ester (non-sulfonated) is a high-performance fluorescent dye in the cyanine dye family, engineered for selective covalent labeling of primary amino groups on proteins, peptides, and oligonucleotides. With excitation and emission maxima at 555 nm and 570 nm respectively, this orange fluorescent dye is optimized for detection using standard fluorescence microscopy and imaging systems equipped with TRITC filters. Its high extinction coefficient (150,000 M⁻¹cm⁻¹) and quantum yield (0.31) ensure sensitive and quantitative signal detection, enabling precise localization and quantification of biomolecules in complex biological samples.

    The dye’s NHS (N-hydroxysuccinimide) ester functional group reacts efficiently with lysine residues or the N-termini of biomolecules, forming stable amide bonds. Its solubility profile—≥59 mg/mL in DMSO and ≥25.3 mg/mL in ethanol (with sonication)—allows for concentrated stock solutions, crucial for workflows needing minimal organic co-solvent. Because Cy3 NHS ester (non-sulfonated) is not water soluble, careful handling with anhydrous solvents is essential, especially for sensitive protein labeling where excessive organic solvent could compromise biomolecular integrity.

    Step-by-Step Workflow: Optimizing Labeling for Proteins, Peptides, and Oligonucleotides

    1. Preparation of Labeling Reaction

    • Stock Solution: Dissolve Cy3 NHS ester (non-sulfonated) at up to 59 mg/mL in anhydrous DMSO. Protect from light and store at -20°C; use freshly prepared solutions for best results.
    • Buffer Selection: Use amine-free buffers (e.g., 50 mM sodium bicarbonate, pH 8.3) to avoid competition with target amino groups. Avoid Tris, glycine, or other primary amine-containing buffers.
    • Sample Preparation: Desalt biomolecules into labeling buffer via dialysis or spin columns. Concentration should be ≥1 mg/mL for proteins, ≥50 μM for peptides, or ≥20 μM for oligonucleotides.

    2. Labeling Reaction

    • Add Dye: Mix Cy3 NHS ester in DMSO with your biomolecule at a molar ratio of 3–10:1 (dye:protein). For oligonucleotides, 5–10 fold excess is typical.
    • Reaction Conditions: Incubate for 30–60 min at room temperature, protected from light. For delicate proteins, keep organic solvent below 10% v/v to minimize denaturation.
    • Quenching: Add 10 mM Tris-HCl (pH 7.5) or ethanolamine post-reaction to quench unreacted NHS ester.

    3. Purification and Quality Control

    • Removal of Free Dye: Use gel filtration (e.g., Sephadex G-25), spin desalting columns, or dialysis. For oligonucleotides, ethanol precipitation or HPLC may be preferred.
    • Degree of Labeling (DOL): Calculate DOL by absorbance at 280 nm (protein) and 550–570 nm (Cy3). A DOL of 1–3 dyes/protein is typical for optimal fluorescence without functional impairment.
    • Storage: Store labeled biomolecules at 4°C in the dark. Avoid repeated freeze-thaw cycles; do not store dye solutions long-term.

    Advanced Applications: From Organelle Imaging to Targeted Degradation

    Cy3 NHS ester (non-sulfonated) is foundational for diverse biomedical imaging and targeted degradation strategies. Its robust fluorescent signal and compatibility with modular chemistries enable integration into nanoparticle assembly, super-resolution microscopy, and live-cell imaging workflows.

    1. Nanoparticle-Mediated Organelle Labeling

    Recent innovations such as NanoTACOrg platforms (Li et al., ACS Nano, 2025) leverage Cy3-labeled peptides or proteins to visualize and quantify targeted sequestration and degradation of specific organelles. Here, Cy3-labeled targeting ligands are conjugated to nanoparticles (e.g., PLGA or gold nanoparticles), allowing real-time tracking of cellular uptake, endosomal escape, and sub-organelle localization. The orange fluorescence of Cy3 is spectrally distinct from green (FITC, GFP) or far-red (Cy5) labels, supporting multiplexed imaging and quantitative colocalization studies.

    2. Protein and Peptide Labeling for Autophagy Studies

    Protein labeling with Cy3 NHS ester enables direct visualization of autophagy receptor oligomerization, aggregate formation, and degradation, as highlighted in reference workflows (see this article). In the context of p62 aggregate-mimicking nanoassemblies, Cy3-labeled peptides can be used to monitor recruitment and clustering dynamics, enabling precise quantification of autophagosome formation and cargo encapsulation. This approach complements and extends the findings from organelle-selective autophagy studies, offering a sensitive readout for mechanistic dissection.

    3. Oligonucleotide and DNA Labeling

    Cy3 NHS ester’s efficiency as an oligonucleotide labeling dye supports FISH (fluorescence in situ hybridization), real-time PCR probes, and single-molecule tracking. Because the dye is covalently linked, labeled oligos exhibit high photostability and minimal background, critical for quantitative genomics and transcriptomics workflows.

    4. Comparative Performance

    Compared to sulfo-Cy3 NHS esters, the non-sulfonated variant offers higher cell permeability, making it ideal for intracellular labeling and nanoparticle integration. However, for highly sensitive proteins or in aqueous-only systems, water-soluble sulfo-Cy3 NHS ester may minimize organic solvent use. For most advanced imaging and degradation workflows, the superior signal-to-noise ratio and labeling efficiency of Cy3 NHS ester (non-sulfonated) are decisive advantages.

    Troubleshooting & Optimization: Maximizing Labeling Efficiency and Signal

    • Low Fluorescence Signal: Check DOL; under-labeling can result from insufficient dye or short incubation. Increase dye ratio or reaction time (up to 2 hours), ensuring protein stability is maintained.
    • Protein Precipitation: Excess organic solvent or high dye ratios can denature proteins. Reduce DMSO/DMF content to below 10% v/v and use gentle mixing. Pre-test protein stability if necessary.
    • High Background or Free Dye: Incomplete removal of unreacted dye is a common issue. Repeat gel filtration or use spin columns with appropriate molecular weight cutoffs. Verify by measuring absorbance at 570 nm in the filtrate.
    • Batch-to-Batch Variability: Standardize reaction conditions (pH, temperature, molar ratios) and always use freshly prepared dye solutions. Store the product as a solid at -20°C in the dark for shelf-life up to 24 months.
    • Photobleaching: Cy3 NHS ester offers good photostability, but minimize light exposure during and after labeling. Store labeled samples in the dark and use anti-fade mounting media for microscopy.

    For advanced troubleshooting and workflow optimization, the article "Cy3 NHS Ester (Non-Sulfonated): Illuminating the Frontier" provides an in-depth look at experimental best practices and competitive benchmarking, offering actionable tips for translational researchers seeking maximal sensitivity and reproducibility.

    Future Outlook: Expanding the Frontiers of Biomedical Imaging and Targeted Degradation

    As nanoparticle-mediated autophagy and targeted organelle degradation gain traction in translational research, the demand for robust, sensitive labeling tools is surging. Cy3 NHS ester (non-sulfonated) is poised to enable new breakthroughs, from live-cell tracking of engineered nanoassemblies to multiplexed imaging of metabolic reprogramming in cancer models. Emerging workflows, as described in "Reinventing Organelle-Targeted Imaging and Degradation", highlight the synergy between innovative labeling chemistries and next-generation imaging platforms.

    Ongoing advances in nanoparticle design, bioorthogonal conjugation, and super-resolution microscopy will further elevate the role of Cy3 NHS ester (non-sulfonated) as the gold-standard fluorescent dye for amino group labeling. As workflows become increasingly modular and quantitative, integrating Cy3 NHS ester labeling with orthogonal detection modalities (e.g., mass spectrometry, single-molecule fluorescence) will unlock new layers of biological insight.

    In summary, Cy3 NHS ester (non-sulfonated) stands at the intersection of sensitivity, specificity, and workflow versatility. Whether advancing protein and peptide imaging, driving nanoparticle-based degradation assays, or pioneering multiplexed omics, this dye empowers researchers to probe, quantify, and manipulate biomolecules with unprecedented precision.